Results 91 to 100 of about 10,362,887 (235)

fluoroscoPy guided cHeMical luMbar syMPatHectoMy for lower liMb iscHaeMic ulcers

open access: yesJournal of Nepal Medical Association, 2006
The purpose of this study was to assess the effectiveness of chemical lumbar sympathectomy in relieving pain and healing ischaemic ulcers in patients with peripheral vascular diseases.
Bal Krishna Bhattarai   +4 more
doaj   +1 more source

Long posterior-flap myoplastic below-knee amputation (Burgess operation) in peripheral vascular disease [PDF]

open access: yes, 1975
Two problems face the surgeon when he decides to amputate. He must try to obtain primary healing of the skin flaps and he must give the patient a strong, mobile and useful stump. These two aims are in part in opposition to each other.
Cutajar, L.
core  

Exploring Determinants of Foot Self‐Care Behaviors Across Adherence Levels in Patients With Diabetic Foot Ulcer History: A Quantile Regression Approach

open access: yesNursing &Health Sciences, Volume 27, Issue 2, June 2025.
ABSTRACT This study explored factors influencing foot self‐care behaviors across adherence in patients with a diabetic foot ulcers history using quantile regression analysis. A descriptive cross‐sectional design was employed, and 130 patients receiving outpatient treatment at a tertiary hospital in South Korea were recruited through convenience ...
Byung Kwan Kim   +3 more
wiley   +1 more source

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

open access: yesInternational Journal of Inflammation, 2013
Thromboangiitis obliterans (TAO) is a nonatherosclerotic, segmental inflammatory disease that most commonly affects the small and medium-sized arteries and veins in the upper and lower extremities.
Abhishek Vijayakumar   +2 more
doaj   +1 more source

SCD‐plus features and AD biomarkers in cognitively unimpaired samples: A meta‐analytic approach for nine cohort studies

open access: yesAlzheimer's &Dementia, Volume 21, Issue 5, May 2025.
Abstract INTRODUCTION Specific features of subjective cognitive decline (SCD‐plus) have been proposed to indicate an increased risk of preclinical Alzheimer's disease (AD). However, few studies have examined how these features relate to AD biomarkers in cognitively unimpaired (CU) older adults. METHODS Meta‐analyses were performed using cross‐sectional
Elizabeth Kuhn   +38 more
wiley   +1 more source

Advancements in mesenchymal stem cell treatment for Buerger's disease [PDF]

open access: yes, 2017
Birgerova bolest (thromboangiitis obliterans) je neaterosklerotski inflamatorni proces koji uglavnom zahvata male i srednje arterije i vene u donjim i gornjim udovima. Okarakterisan je kao vrsta vaskulitisa.
Fazlagić, Amira   +6 more
core   +1 more source

MANAGEMENT OF BUERGER'S DISEASE THROUGH AYURVEDA- A CASE REPORT [PDF]

open access: yes, 2020
The present case report was about a 50 year-old-male who was diagnosed with Buerger’s disease which is a generalised occlusive vascular diseaseaffecting predominantly males with special predilection to involve the lowerextremities.
Divya Kajaria   +2 more
core   +2 more sources

Risk of Raynaud's Phenomenon Among Workers in the Occupational Disease Surveillance System

open access: yesAmerican Journal of Industrial Medicine, Volume 68, Issue 4, Page 344-357, April 2025.
ABSTRACT Introduction Raynaud's phenomenon (RP) is linked to occupational exposures such as vibration, cold temperature, and chemicals. However, large cohort studies examining RP by occupation and sex are scarce. To address this gap, this study aimed to assess risk of RP by both occupation and sex in a large cohort of workers in Ontario, Canada ...
Ryann E. Yeo   +3 more
wiley   +1 more source

Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs:The CVD-REAL study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) [PDF]

open access: yes, 2017
Background: Reduction in cardiovascular death and hospitalization for heart failure (HHF) was recently reported with the sodium-glucose cotransporter-2 inhibitor (SGLT-2i) empagliflozin in patients with type 2 diabetes mellitus ...
Arya, Niki   +13 more
core   +2 more sources

Enabling Mesenchymal Stromal Cells and Their Extracellular Vesicles Clinical Availability—A Technological and Economical Evaluation

open access: yesJournal of Extracellular Biology, Volume 4, Issue 3, March 2025.
Design and simulation of a manufacturing platform for producing clinical‐grade doses of mesenchymal stromal cells (MSC) and MSC‐derived extracellular vesicles (MSC‐EV). The platform achieves competitive selling prices for MSC doses ranging from 10 to 100 million cells, and offers even more attractive prices for MSC‐EV, with dosages of 1010 and 1011 EV.
Ricardo M. Silva   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy